Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

BB2 > Dementia > Flashcards

Dementia Flashcards

1
Q

What is dementia?

A

A term used to describe a syndrome that may be caused by a number of illnesses in which there is progressive decline in multiple areas of function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In dementia, what are the three main symptoms?

A

Decline in memory and reasoning
Decline in communication skills
Inability to carry out daily activities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the behavioural and psychological symptoms of dementia? (8)

A 
agitation
aggression
wandering
shouting
repeated questioning
sleep disturbance
depression
psychosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What accounts for 62% of dementia cases?

What other types of dementia are there?

A 
Alzheimer's disease
Vascular dementia (17%), mixed AD and vascular dementia (10%), Lewy body dementia (4%), frontal temporal (2%), PD (2%) and others (3%).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the non-modifiable risk factors for dementia? (4)

A

Age, genetic predisposition, family history, Downs syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the modifiable risk factors for dementia? (4)

A

Vascular risk factors (high cholesterol, hypertension, diabetes)
Cognitive inactivity
Environment
Depression and other psychiatric diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the two classic histological signs seen in AD?

A

Extracellular depositions of amyloid protein forming plaques

Intraneuronal depositions of hyper-phosphorylated tau, forming neurofibrillary tangles in cell bodies and neurites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What peptide forms these senile plaques?

Where is it also deposited?

A

Beta-amyloid peptide

Cerebral vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In AD, there is significant loss of what type of neurotransmitter cell?

A

Cholinergic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In AD, there is neuritic dystrophy and synaptic loss, as well as selective neuronal cell loss. What does this all cause?

A

Neuronal dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What three genes are linked to early-onset AD? What chromosomes are they located on?

A

APP - chromosome 21
PSEN1 - chromosome 14
PSEN2 - chromosome 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

APP is a single transmembrane polypeptide.

Where is it expressed? (4)

A

Neurones
Glial cells
Endothelial cells
Smooth muscle cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does APP encode and what is this protein’s function?

A

Amyloid precursor protein

It is cleaved to form amyloidogenic A-beta peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are mutations in APP associated with?

A

Early onset AD

Cerebral amyloid angiopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How many mutations have been found in APP? What do they generally do?

A

29

Increase A-beta production (there is one, A673T, that decreases production)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is presenilin-1?

How many mutations have been reported?

A

A subunit of gamma-secretase, the aspartyl protease responsible for A-beta generation.
189

17
Q

What is the most common cause of early onset AD?

A

PSEN1 mutation

18
Q

How many mutations in PSEN2 have been identified? Are these a common cause of AD?

A

24

No - rare cause of early onset AD

19
Q

APP is cleaved by three secretase enzymes. What are they?

A

Alpha, beta and gamma

20
Q

What secretases are used for the non-amyloidogenic pathway?

A

Alpha and gamma

21
Q

What secretases are used for the amyloidogenic pathway?

What does this pathway generate?

A

Beta and gamma

A-beta amyloid peptide (39-43)

22
Q

What is the causal sequence of pathogenic steps of familial forms of AD? (10 steps)

A
  1. Genetic missense mutations in APP, PS1,PS2
  2. Increased proteolysis and production of APP
  3. Progressive accumulation of Aβ in brain interstitial fluid
  4. Deposition of aggregated Aβ40/Aβ42 as diffuse plaques
  5. “Inflammatory” response (microglial activation, astrocytosis and acute phase protein release)
  6. Progressive neuritic injury within amyloid plaques
  7. Disruption of neuronal metabolism and ionic homeostasis (oxidative stress)
  8. Altered kinase/phosphatase activity, which causes hyperphosphorylation of tau.
  9. Formation of neurofibrillary tangles
  10. Widespread neuronal/neuritic dysfunction and death in hippocampus and cerebral cortex and progressive neurotransmitter deficits

–> DEMENTIA

23
Q

What gene is associated with late-onset AD?

A

Apolipoprotein E - chromosome 19

24
Q

What is ApoE? How many isoforms are there?

Why are these different isoforms important?

A

A lipoprotein involved in cholesterol metabolism
3 isoforms (2, 3 and 4)
The isoforms determine your risk - ApoE4 has the greatest risk (it decreases clearance of extracellular A-beta) and ApoE2 is protective against AD.

25
Q

What is the function of tau?

How is this maintained?

A

It stabilises microtubules through four tubulin binding domains.
This is maintained in equilibrium by the actions of kinases and phosphatases. The phosphorylation of tau regulates its ability to bind to microtubules and so affects axonal transport.

26
Q

What happens when tau becomes hyper-phosphorylated?

A

It dissociates from microtubules and they disassemble, causing neuronal loss.
Hyperphosphorylated, aggregated tau forms the neurofibrillary tangles.

27
Q

What does MAPT encode?

Whatt are mutations in this linked to?

A

Microtubule associated protein Tau

Frontotemporal dementia and other Tauopathies

28
Q

What are the current established CSF markers?

A

Decreased amyloid-beta 40 and 42 in the CSF

Increased p-tau 181,231/total tau/phospho-tau in CSF

29
Q

In the future, what blood based markers could be used to diagnose AD?

A

Protein
DNA/RNA
Lipids

30
Q

On MRI in patients with AD, what can be seen?

A

Reduction in brain volume

Enlarged ventricles

31
Q

What can be used in PET scans to visualise A-beta plaques?

What about tau?

A

C11 Pittsburgh Compound B

FDG

32
Q

What pathways degenerate in AD?

A

Cholinergic forebrain pathways innervating cortical and limbic structures

33
Q

Name three acetylcholinesterase inhibitors.
Who are they recommended for?
What are they modestly efficacious on?

A

Donepezil, galantamine and rivastigmine
Those with mild to moderate Alzheimer’s disease
Cognitive symptoms

34
Q

Name a NMDA receptor antagonist.
Who is it recommended for?
What are they modestly efficacious on?

A

Memantine

Those with moderate AD who are intolerant to AChE inhibitors, and those with severe AD

35
Q

What are the symptomatic treatments for AD?

A

Antidepressant drugs
Antipsychotic drugs
Mood stabilisers

36
Q

What are the side effects of memantine?

A

Dizziness, headaches, tiredness, increased blood pressure and constipation.

37
Q

AD may be associated with a slow form of excitotoxicity and increased glutamate. What can excessive calcium ions lead to?

A

Free radicals
ROS
Mitochondrial dysfunction

38
Q

What are the potential future treatments for AD? (6)

A

β-secretase inhibitors
Notch-sparing γ-secretase inhibitors or modulators
Aβ vaccines and monoclonal antibodies
Aβ aggregation inhibitors
Tau lowering/anti aggregation compounds
Regulation of abnormal anti-inflammatory mechanisms

BB2 (32 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions